advisorsecurities master

EYPTEyePoint, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
15096
Ticker
EYPT
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2005-01-27
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
EYPT

Detail

Enriched 2026-08-14 20:47

Market cap
$1,166,450,227.14
Shares outstanding (class)
86,212,138
Shares outstanding (weighted)
86,212,138
SIC
3826 LABORATORY ANALYTICAL INSTRUMENTS
Employees
214
Location
WATERTOWN, MA
Description

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data